Plasma samples were analyzed by ELISA
Results from 327 women demonstrated: Significant increases in satisfying sexual events compared to placebo at 1.25 mg and 1.75 mg doses Improved Female Sexual Function Index total scores (mean improvement of 3.6 points vs 1.9 for placebo) Reduced sexual distress as measured by Female Sexual Distress Scale scores Dose-dependent response with optimal effects at 1.75 mg Two Phase 3 trials (RECONNECT studies) enrolled over 1,200 premenopausal women with acquired, generalized HSDD and confirmed efficacy at the 1.75 mg dose administered subcutaneously at least 45 minutes before anticipated sexual activity
A Flexible Spending Account (FSA) is similar but is usually offered through an employer
Glutathione supplements are generally considered safe for anyone who isnt pregnant, breastfeeding, or hypersensitive
250:8487-8495 [PubMed: 172501] 11
Storage Readiness Assessment: A Clinical Framework Before beginning semaglutide, evaluate whether your living situation, work environment, and travel patterns support consistent refrigeration
